Investigation of the solution-phase structure of macrocyclic anti-leukemia drug midostaurin
Physical Chemistry Chemical Physics · 2026 · 28 (17) · 10457-10461
DOI: 10.1039/d5cp04820f ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical Chemistry Chemical Physics, 2026. Verfasst von Zeyan Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Photonic and Electronic Bandgap Materials, Ministry of Education, College of Chemistry & Chemical Engineering, Harbin Normal Unive…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Staurosporine, Macrocyclic Compounds. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Natural Science Foundation of Heilongjiang Province.
Abstract (Originalsprache)
Investigation of the solution-phase structure of macrocyclic anti-leukemia drug midostaurin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Photonic and Electronic Bandgap Materials, Ministry of Education, College of Chemistry & Chemical Engineering, Harbin Normal University, Harbin, 150025, China. wangzq@hrbnu.edu.cn.
Förderung
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Jiang, Z., Wang, Q., Xu, H., Lv, Y., Lei, Y., Jin, Y., Sun, Y., & Wang, Z. (2026). Investigation of the solution-phase structure of macrocyclic anti-leukemia drug midostaurin. Physical Chemistry Chemical Physics, 28(17), 10457-10461. https://doi.org/10.1039/d5cp04820f
Vancouver
Jiang Z, Wang Q, Xu H, Lv Y, Lei Y, Jin Y, et al. Investigation of the solution-phase structure of macrocyclic anti-leukemia drug midostaurin. Physical Chemistry Chemical Physics. 2026;28(17):10457-10461. doi:10.1039/d5cp04820f
BibTeX
@article{Jiang2026,
author = {Jiang, Zeyan and Wang, Qi and Xu, Hongyu and Lv, Yang and Lei, Yue and Jin, Yingxue and Sun, Yimeng and Wang, Zhiqiang},
title = {Investigation of the solution-phase structure of macrocyclic anti-leukemia drug midostaurin},
journal = {Physical Chemistry Chemical Physics},
year = {2026},
volume = {28},
number = {17},
pages = {10457--10461},
doi = {10.1039/d5cp04820f}
}
EUVIMED